Differential expression analysis between type I and type II enterocytes identified 883 type II enterocyte-enriched genes
Liu, Y., Kubota, S., Iizuka, K
Association of semaglutide with incident and recurrent AUD diagnosis in patients with T2DM The study population for the analysis of incident AUD diagnosis in patients with T2DM consisted of 598,803 patients with T2DM who had no prior diagnosis of AUD and were for the first time prescribed semaglutide or non-GLP-1RA anti-diabetes medications in 12/20175/2021
funded by the Carl-Zeiss-Stiftung)
Some may also hope that weight-loss results will be sustained without it
There are concerns about GLP-1 and GLP-1/GIP medications being purchased without a prescription through unregulated or illicit channels, with very light medical supervision or being used outside their licensed use (i.e